Oruka Therapeutics股价大涨20%,达到八个月以来的最高水平。该公司宣布其实验性银屑病治疗药物的早期阶段研究获得积极结果,推动股价强劲上扬。
Oruka Therapeutics股价大涨20%,达到八个月以来的最高水平。该公司宣布其实验性银屑病治疗药物的早期阶段研究获得积极结果,推动股价强劲上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.